Bausch Health Companies (BHC) Net Income towards Common Stockholders (2016 - 2025)
Bausch Health Companies' Net Income towards Common Stockholders history spans 17 years, with the latest figure at -$103.0 million for Q4 2025.
- For Q4 2025, Net Income towards Common Stockholders fell 205.1% year-over-year to -$103.0 million; the TTM value through Dec 2025 reached $120.0 million, up 266.67%, while the annual FY2025 figure was $120.0 million, 266.67% up from the prior year.
- Net Income towards Common Stockholders for Q4 2025 was -$103.0 million at Bausch Health Companies, down from $181.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $403.0 million in Q3 2022 and bottomed at -$680.0 million in Q1 2021.
- The 5-year median for Net Income towards Common Stockholders is -$71.5 million (2022), against an average of -$93.0 million.
- The largest annual shift saw Net Income towards Common Stockholders tumbled 669.44% in 2022 before it skyrocketed 12900.0% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $72.0 million in 2021, then crashed by 669.44% to -$410.0 million in 2022, then skyrocketed by 88.54% to -$47.0 million in 2023, then surged by 308.51% to $98.0 million in 2024, then plummeted by 205.1% to -$103.0 million in 2025.
- Per Business Quant, the three most recent readings for BHC's Net Income towards Common Stockholders are -$103.0 million (Q4 2025), $181.0 million (Q3 2025), and $128.0 million (Q2 2025).